AbbVie is set to release its first-quarter financial outcomes for 2025 on April 25, prior to the market opening. A live webcast of the earnings conference call will be hosted by AbbVie at 8 a.m. Central time, accessible via their Investor Relations website at investors.abbvie.com. A recording of the webcast will be made available later the same day.
AbbVie focuses on creating and delivering innovative medicines to tackle pressing health issues and future medical challenges. The company aims to significantly impact lives through its work in areas such as immunology, oncology, neuroscience, eye care, and Allergan Aesthetics products and services.
For more information, visit AbbVie's website at www.abbvie.com or follow them on their social media platforms, including LinkedIn, Facebook, Instagram, X, and YouTube.
Contact information for media and investors is as follows:
Gabby Tarbert, (224) 244-0111, gabrielle.tarbert@abbvie.com
Liz Shea, (847) 935-2211, liz.shea@abbvie.com
"AbbVie will announce its first-quarter 2025 financial results on Friday, April 25, 2025, before the market opens."
"AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time."
###